Should we be using psychedelics or dissociatives to treat mental health conditions?

Zenodo (CERN European Organization for Nuclear Research) 2026 Preprint Open access

Read full text
Authors: Cassidy O'Brien, Sabrina Fields
DOI: 10.5281/zenodo.18988759
Cited by: 0

Abstract

This white paper was developed for BIOL 700, a seminar-style course at the University of New Hampshire that explores the intersection of biological science, ethics, and public policy. The report provides a comprehensive analysis of the clinical and ethical debate surrounding the question: "Should psychedelics or dissociatives be utilized as primary treatments for mental health conditions?"

Fields of Study & Subjects

Psychedelics and Drug Studies Neuroethics Human Enhancement Biomedical Innovations Treatment of Major Depression

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
12 March 2026
Language
EN
Document type
Preprint